BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Treatment
67 results:

  • 1. Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial.
    Janjigian YY; Kawazoe A; Bai Y; Xu J; Lonardi S; Metges JP; Yanez P; Wyrwicz LS; Shen L; Ostapenko Y; Bilici M; Chung HC; Shitara K; Qin SK; Van Cutsem E; Tabernero J; Li K; Shih CS; Bhagia P; Rha SY;
    Lancet; 2023 Dec; 402(10418):2197-2208. PubMed ID: 37871604
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A predictive scoring model to select suitable patients for surgery on primary tumor in metastatic esophageal cancer.
    Wei L; Xu J; Hu X; Xie Y; Lyu G
    Cancer Rep (Hoboken); 2023 Dec; 6(12):e1898. PubMed ID: 37702247
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Early Improved Functional Outcomes in head and neck cancer Patients with Primary Tumor Detection.
    Kalavacherla S; Bernard B; Kim SS; Dornisch A; Blumenfeld L; Linnemeyer-Risser K; Sanghvi P; Guo T
    Laryngoscope; 2024 Feb; 134(2):701-707. PubMed ID: 37462352
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Analysis of risk factors for recurrence of differentiated thyroid carcinoma after surgical resection combined with iodine-131 and TSH suppression therapy].
    Ye T; Lai S; Cao B; Xu B; Wang R
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 May; 37(5):370-374. PubMed ID: 37138400
    [No Abstract]    [Full Text] [Related]  

  • 5. Epidemiological and clinical characteristics of synchronous lung metastasis in major salivary gland mucoepidermoid carcinoma.
    Li Y; Hu C
    Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3835-3841. PubMed ID: 37100896
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pre-immunotherapy radiotherapy enhanced the efficacy of multi-line sintilimab in unresectable advanced esophageal squamous cell carcinoma.
    Xu S; Xu X; Zhu H
    Front Immunol; 2023; 14():960339. PubMed ID: 36891294
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Evaluation of Concomitant Systemic treatment in Older Adults With head and neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy.
    Rühle A; Marschner S; Haderlein M; Fabian A; Weymann M; Behrens M; Senger C; Dickstein DR; Kraft J; von der Grün J; Chen E; Aquino-Michaels T; Domschikowski J; Bickel A; Altay-Langguth A; Kalinauskaite G; Lewitzki V; Ferentinos K; Zamboglou C; Schnellhardt S; Haehl E; Spohn SKB; Gkika E; Zöller D; Guckenberger M; Budach V; Belka C; Bakst R; Mayer A; Schmidberger H; Grosu AL; Balermpas P; Stromberger C; Nicolay NH
    JAMA Netw Open; 2023 Feb; 6(2):e230090. PubMed ID: 36808242
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. More than cervical cancer: Understanding racial/ethnic disparities in oropharyngeal cancer outcomes among males by HPV status.
    Villalona S; Ferrante J; Villalona S; Stroup A
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696662
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Afatinib maintenance therapy following post-operative radiochemotherapy in head and neck squamous cell carcinoma: Results from the phase III randomised double-blind placebo-controlled study BIB2992ORL (GORTEC 2010-02).
    Racadot S; Thennevet I; Ouldbey Y; Kaminsky MC; Bosset M; Martin L; Tao Y; Sire C; de Raucourt D; Alfonsi M; Malaurie E; Tourani JM; Fournel P; Vauleon E; Modesto A; Rolland F; Metzger S; Pommier P; Chabaud S; Dussart S;
    Eur J Cancer; 2023 Jan; 178():114-127. PubMed ID: 36434888
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic models for early and late tumor progression prediction in nasopharyngeal carcinoma: An analysis of 8292 endemic cases.
    Zhang LL; Zheng WH; Zhu WJ; Deng QL; Peng JL; Li YY; Sun Y; Lin L
    Cancer Med; 2023 Mar; 12(5):5384-5396. PubMed ID: 36301691
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven cancers.
    Ghosh S; Mazumdar T; Xu W; Powell RT; Stephan C; Shen L; Shah PA; Pickering CR; Myers JN; Wang J; Frederick MJ; Johnson FM
    Clin Cancer Res; 2022 Oct; 28(20):4479-4493. PubMed ID: 35972731
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma.
    Yue H; Zhu H; Luo D; Du Q; Xie Y; Huang S; Liu W
    Comput Math Methods Med; 2022; 2022():1941412. PubMed ID: 35509856
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.
    Lassen P; Huang SH; Su J; Waldron J; Andersen M; Primdahl H; Johansen J; Kristensen CA; Andersen E; Eriksen JG; Hansen CR; Alsner J; Lilja-Fisher J; Bratman SV; Ringash J; Kim J; Hope A; Spreafico A; de Almeida J; Xu W; O'Sullivan B; Overgaard J
    Int J Cancer; 2022 Apr; 150(8):1329-1340. PubMed ID: 34792199
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.
    Findlay M; White K; Brown C; Bauer JD
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2187-2198. PubMed ID: 34676673
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Nomogram prediction for the involution of the ablation zone after radiofrequency ablation treatment in patients with low-risk papillary thyroid carcinoma.
    He H; Zhang Y; Song Q; Zhao J; Li W; Li Y; Luo Y
    Int J Hyperthermia; 2021; 38(1):1133-1139. PubMed ID: 34348562
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Favorable outcomes of papillary thyroid microcarcinoma concurrent with Graves' disease after radioactive iodine therapy.
    Nishihara E; Ito Y; Kudo T; Ito M; Fukata S; Nishikawa M; Akamizu T; Miyauchi A
    Endocr J; 2021 Jun; 68(6):649-654. PubMed ID: 33551434
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Changes in hospital variation in the probability of receiving treatment with curative intent for esophageal and gastric cancer.
    Luijten JCHBM; Vissers PAJ; Lingsma H; van Leeuwen N; Rozema T; Siersema PD; Rosman C; van Laarhoven HWM; Lemmens VEP; Nieuwenhuijzen GAP; Verhoeven RHA
    Cancer Epidemiol; 2021 Apr; 71(Pt A):101897. PubMed ID: 33484974
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Nomograms for predicting survival in early-onset esophageal cancer.
    Shi M; Tang JW; Cao ZR
    Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):437-446. PubMed ID: 33121317
    [No Abstract]    [Full Text] [Related]  

  • 19. Primary cutaneous melanoma of the scalp: Patterns of clinical, histological and epidemiological characteristics in Brazil.
    Porto AC; Pinto Blumetti T; Oliveira Santos Filho IDA; Calsavara VF; Duprat Neto JP; Tavoloni Braga JC
    PLoS One; 2020; 15(10):e0240864. PubMed ID: 33095773
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a head and neck cancer.
    Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
    JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.